{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:33:14Z","timestamp":1791304394678,"version":"4.3.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,28]]},"DOI":"10.7759\/cureus.19966","type":"journal-article","created":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T20:03:01Z","timestamp":1638129781000},"source":"Crossref","is-referenced-by-count":6,"title":["Primary Pericardial Mesothelioma: A Rare but Serious Consideration"],"prefix":"10.7759","author":[{"given":"Steffan","family":"Seal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(88)90033-6","article-title":"Magnetic resonance imaging findings in a patient with pericardial mesothelioma","volume":"115","author":"G\u00f6ssinger HD","year":"1988","unstructured":"G\u00f6ssinger HD, Siostrzonek P, Zangeneh M, et al.. Magnetic resonance imaging findings in a patient with pericardial mesothelioma. Am Heart J. 1988, 115:1321-2. 10.1016\/0002-8703(88)90033-6","journal-title":"Am Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.90.1.e4","article-title":"Primary pericardial mesothelioma presenting as pericardial constriction: a case report","volume":"90","author":"Suman S","year":"2004","unstructured":"Suman S, Schofield P, Large S. Primary pericardial mesothelioma presenting as pericardial constriction: a case report. Heart. 2004, 90:10.1136\/heart.90.1.e4","journal-title":"Heart"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-019-0728-4","article-title":"The imaging appearances of various pericardial disorders","volume":"10","author":"\u00dcnal E","year":"2019","unstructured":"\u00dcnal E, Karcaaltincaba M, Akpinar E, Ariyurek OM. The imaging appearances of various pericardial disorders. Insights Imaging. 2019, 10:10.1186\/s13244-019-0728-4","journal-title":"Insights Imaging"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/000228894","article-title":"Primary pericardial mesothelioma: report of a patient and literature review","volume":"2","author":"Nilsson A","year":"2009","unstructured":"Nilsson A, Rasmuson T. Primary pericardial mesothelioma: report of a patient and literature review. Case Rep Oncol. 2009, 2:125-32. 10.1159\/000228894","journal-title":"Case Rep Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.81.4.520","article-title":"Pericardial mesothelioma","volume":"81","author":"Yilling FP","year":"1982","unstructured":"Yilling FP, Schlant RC, Hertzler GL, Krzyaniak R. Pericardial mesothelioma. Chest. 1982, 81:520-3. 10.1378\/chest.81.4.520","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1053\/j.semtcvs.2021.07.020","article-title":"Primary pericardial mesothelioma: a population-based propensity score-matched analysis. [In Press]","author":"Brydges H","year":"2021","unstructured":"Brydges H, Yin K, Balasubramaniyan R, et al.. Primary pericardial mesothelioma: a population-based propensity score-matched analysis. [In Press]. Semin Thorac Cardiovasc Surg. 2021, 10.1053\/j.semtcvs.2021.07.020","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/283601","article-title":"Primary pericardial mesothelioma: a rare entity","volume":"2013","author":"Godar M","year":"2013","unstructured":"Godar M, Liu J, Zhang P, Xia Y, Yuan Q. Primary pericardial mesothelioma: a rare entity. Case Rep Oncol Med. 2013, 2013:10.1155\/2013\/283601","journal-title":"Case Rep Oncol Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas P","year":"2021","unstructured":"Baas P, Scherpereel A, Nowak AK, et al.. First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial. Lancet. 2021, 397:375-386. 10.1016\/S0140-6736(20)32714-8","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/74741-primary-pericardial-mesothelioma-a-rare-but-serious-consideration","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:43Z","timestamp":1707507103000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/74741-primary-pericardial-mesothelioma-a-rare-but-serious-consideration"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,28]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.19966","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,28]]}}}